XML 14 R5.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Consolidated Statements of Comprehensive Loss Parentheticals - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021
Consolidated Statements of Operations [Abstract] |  |  |  |
Stock-based compensation expense associated with research and development expense | $ 939 | $ 1,138 | $ 3,069 | $ 3,608
Stock-based compensation expense associated with selling, general and administrative expense | $ 1,709 | $ 1,574 | $ 5,183 | $ 4,741

X
- Definition Consolidated Statements of Operations [Abstract] + References No definition available. + Details
Name: | lxrx_ConsolidatedStatementsOfOperationsAbstract
Namespace Prefix: | lxrx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock-based compensation expense included in research and development expense. + References No definition available. + Details
Name: | lxrx_StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpense
Namespace Prefix: | lxrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock-based compensation expense associated with selling, general and administrative expense + References No definition available. + Details
Name: | lxrx_Stockbasedcompensationexpenseassociatedwithsellinggeneralandadministrativeexpense
Namespace Prefix: | lxrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration